ESAS and iron

نویسندگان
چکیده

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

petrology and geochemistry of khar-bash (western shahrood) and its relation ship to iron mineralization

منطقه مورد مطالعه در 23 کیلومتری جنوب غرب شهرستاشاهرود قرار دارد که در نقشه 100000/1 شاهرود قرار گرفته است.ناحیه مورد مطالعه در تقسیمات ساختاری ایران بخشی از زون البرز شرقی است . در طی سنوزوئیک این زون به شدت تحت تأثیر فازهای کوهزایی آلپی قرار گرفته و فعالیت های آتشفشانی انوسن در قسمت های غربی آن دیده می شود . از نظر ترکیب سنگ شناسی منطقه مورد مطالعه متنوع و بیشتر شامل سنگ های رسوبی مانند : آ...

15 صفحه اول

Lessons learned from the use of ESAs.

Dr. Bennett and colleagues have provided a thorough and balanced history of the rise and fall of erythropoietin-stimulating agents (ESAs) in cancer-associated anemia. Their review encourages us to think about the lessons learned from this history—lessons about medical progress, the importance of clinical research in guiding clinical practice, and the role of the US Food and Drug Administration ...

متن کامل

Rasch Analysis of the Esas and Research Implications

Cancer and its treatments—including surgery, chemotherapy, radiation, and hormone therapy—are associated with decreased physical function and adverse psychological and emotional effects. Physical symptoms commonly include fatigue, nausea, pain, and decreased strength and endurance1–4. The importance of appreciating the consequences of cancer-related side effects is magnified as the number of pe...

متن کامل

ESAs in transplant anemia: one size does not "fit all".

Anemia, a risk factor for cardiovascular events in patients with CKD, is a common problem following transplantation and has been reported in up to 40%of kidney transplant recipients (KTRs).1–3 It is well established that post-transplant anemia (PTA) is associated with poor clinical outcomes. PTA is associated with increased mortality (18% versus 10% over 4 years), an increased risk of acute rej...

متن کامل

Reassessments of ESAs for cancer treatment in the US and Europe.

Anemia is a widely prevalent complication among cancer patients. At the time of diagnosis, 30% to 40% of patients with non-Hodgkin lymphoma or Hodgkin lymphoma and up to 70% of patients with multiple myeloma are anemic; rates are higher among persons with myelodysplastic syndromes. Among patients with solid cancers or lymphomas, up to half develop anemia following chemotherapy. For almost 2 dec...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Nephrology Dialysis Transplantation

سال: 2013

ISSN: 0931-0509,1460-2385

DOI: 10.1093/ndt/gft138